Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Lung Cancer

  Free Subscription


Articles published in J Comput Assist Tomogr

Retrieve available abstracts of 35 articles:
HTML format



Single Articles


    September 2024
  1. YANG J, Yang C, Feng J, Zhu F, et al
    Predicting Microwave Ablation Early Efficacy in Pulmonary Malignancies via Delta Radiomics Models.
    J Comput Assist Tomogr. 2024;48:794-802.
    PubMed     Abstract available


  2. LIU JC, Sheng J, Xue S, Fang M, et al
    Value of the Air Bronchogram Sign and Other Computed Tomography Findings in the Early Diagnosis of Lung Adenocarcinoma.
    J Comput Assist Tomogr. 2024;48:789-793.
    PubMed     Abstract available


  3. BYRNE SC, Peers C, Gargan ML, Lacson R, et al
    Risk of Malignancy in Incidentally Detected Lung Nodules in Patients Aged Younger Than 35 Years.
    J Comput Assist Tomogr. 2024;48:770-773.
    PubMed     Abstract available


    August 2024
  4. WU L, Wei D, Chen W, Wu C, et al
    Comprehensive Potential of Artificial Intelligence for Predicting PD-L1 Expression and EGFR Mutations in Lung Cancer: A Systematic Review and Meta-Analysis.
    J Comput Assist Tomogr. 2024 Aug 12. doi: 10.1097/RCT.0000000000001644.
    PubMed     Abstract available


  5. PAN X, Xie X, Chen X, Chen H, et al
    High-Resolution CT Patterns of Anti-PD1 Checkpoint Inhibitor-Related Pneumonitis in Patients With Lung Cancer.
    J Comput Assist Tomogr. 2024 Aug 12. doi: 10.1097/RCT.0000000000001643.
    PubMed     Abstract available


    May 2024
  6. KIRIKI M, Koizumi M, Maeda K, Sakai T, et al
    Development of the Split-Bolus Pulmonary Arteriovenous Separating Computed Tomography Angiography Protocol Based on Time Enhancement Curve for Lung Cancer Surgery.
    J Comput Assist Tomogr. 2024 May 2. doi: 10.1097/RCT.0000000000001621.
    PubMed     Abstract available


    March 2024
  7. MAGNINI A, Lorini C, Calistri L, Calcagni F, et al
    The Impact of Rapid On-site Evaluation on Diagnostic Performance of Computed Tomography-Guided Core Needle Biopsy in Lung Cancer.
    J Comput Assist Tomogr. 2024 Mar 22. doi: 10.1097/RCT.0000000000001606.
    PubMed     Abstract available


  8. HU Y, Geng Y, Wang H, Chen H, et al
    Improved Prediction of Epidermal Growth Factor Receptor Status by Combined Radiomics of Primary Nonsmall-Cell Lung Cancer and Distant Metastasis.
    J Comput Assist Tomogr. 2024 Mar 18. doi: 10.1097/RCT.0000000000001591.
    PubMed     Abstract available


    November 2023
  9. SHI J, Chen H, Wang X, Cao R, et al
    Using Radiomics to Differentiate Brain Metastases From Lung Cancer Versus Breast Cancer, Including Predicting Epidermal Growth Factor Receptor and human Epidermal Growth Factor Receptor 2 Status.
    J Comput Assist Tomogr. 2023;47:924-933.
    PubMed     Abstract available


  10. ZHANG Y, Tan W, Zheng Z, Wang J, et al
    Body Composition and Radiomics From 18 F-FDG PET/CT Together Help Predict Prognosis for Patients With Stage IV Non-Small Cell Lung Cancer.
    J Comput Assist Tomogr. 2023;47:906-912.
    PubMed     Abstract available


    October 2023
  11. UDELSMAN BV, Detterbeck F, Tanoue L, Mase V, et al
    Impact of the COVID-19 Pandemic on Lung Cancer Screening Processes in a Northeast Tertiary Health Care Network.
    J Comput Assist Tomogr. 2023 Oct 12. doi: 10.1097/RCT.0000000000001549.
    PubMed     Abstract available


    July 2023
  12. SHI J, Chen H, Wang X, Cao R, et al
    Using Radiomics to Differentiate Brain Metastases From Lung Cancer Versus Breast Cancer, Including Predicting Epidermal Growth Factor Receptor and human Epidermal Growth Factor Receptor 2 Status.
    J Comput Assist Tomogr. 2023 Jul 28. doi: 10.1097/RCT.0000000000001499.
    PubMed     Abstract available


  13. ZHANG Y, Tan W, Zheng Z, Wang J, et al
    Body Composition and Radiomics From 18F-FDG PET/CT Together Help Predict Prognosis for Patients With Stage IV Non-Small Cell Lung Cancer.
    J Comput Assist Tomogr. 2023 Jul 7. doi: 10.1097/RCT.0000000000001496.
    PubMed     Abstract available


    May 2023
  14. YOSHIDA K, Takamatsu A, Toshima F, Kozaka K, et al
    Computer-Aided Detection of Subsolid Nodules on Chest Computed Tomography: Assessment of Visualization on Vessel-Suppressed Images.
    J Comput Assist Tomogr. 2023;47:412-417.
    PubMed     Abstract available


  15. YANG X, Li C, Hou J, Xiong Z, et al
    Differentiating Peripherally Located Pulmonary Noncalcified Hamartoma From Carcinoid Using CT Radiomics Approaches.
    J Comput Assist Tomogr. 2023;47:402-411.
    PubMed     Abstract available


  16. RYAN JW, Hammer MM
    Growth Rates of Pulmonary Carcinoid Tumors and Hamartomas.
    J Comput Assist Tomogr. 2023;47:396-401.
    PubMed     Abstract available


    March 2023
  17. TSENG SC, Gagne SM, Hatabu H, Lin G, et al
    Lung Cancer in Lung Transplant Recipients: Clinical, Radiologic, and Pathologic Characteristics and Treatment Outcome.
    J Comput Assist Tomogr. 2023 Mar 9. doi: 10.1097/RCT.0000000000001466.
    PubMed     Abstract available


  18. NIU S, Zhang H, Wang X, Jiang W, et al
    Radiomics of Spinal Metastases Originating From Primary Nonsmall Cell Lung Cancer or Breast Cancer and Ability to Predict Epidermal Growth Factor Receptor Mutation/Ki-67 Levels.
    J Comput Assist Tomogr. 2023 Mar 9. doi: 10.1097/RCT.0000000000001465.
    PubMed     Abstract available


    January 2023
  19. MAEHARA Y, Miura H, Hirota T, Asai S, et al
    Frequency and Risk Factors for Air Embolism in Computed Tomography Fluoroscopy-Guided Biopsy of Lung Tumor With the Use of Noncoaxial Automatic Needle.
    J Comput Assist Tomogr. 2023;47:71-77.
    PubMed     Abstract available


    December 2022
  20. INOUE A, Johnson TF, Walkoff LA, Levin DL, et al
    Lung Cancer Screening Using Clinical Photon-Counting Detector Computed Tomography and Energy-Integrating-Detector Computed Tomography: A Prospective Patient Study.
    J Comput Assist Tomogr. 2022 Dec 27. doi: 10.1097/RCT.0000000000001419.
    PubMed     Abstract available


    November 2022
  21. XIE X, Dong M, Zhang L, Ding D, et al
    With the Increasing Health Awareness: Clinical and Computed Tomography Findings in Primary Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma Lymphoma.
    J Comput Assist Tomogr. 2022;46:894-899.
    PubMed     Abstract available


  22. ZHONG Y, Xu H, Zhang W, Li H, et al
    Radiomic Analysis of Pulmonary Nodules for Distinguishing Malignancy From Benignancy: The Value of Using Iodine Maps From Dual-Energy Computed Tomography.
    J Comput Assist Tomogr. 2022;46:878-883.
    PubMed     Abstract available


    April 2022
  23. JIANG J, Leng Y, Liu J, Yin J, et al
    Volumetric Analysis of Intravoxel Incoherent Motion Diffusion-Weighted Imaging for Predicting the Response to Chemotherapy in Patients With Locally Advanced Non-Small Cell Lung Cancer.
    J Comput Assist Tomogr. 2022 Apr 8. pii: 00004728-990000000-00003.
    PubMed     Abstract available


  24. QI LP, Li XT, Ma ZM, Yang Y, et al
    Preoperative Patient and Lesion Features Are Valuable for Predicting the Prognosis of Resectable Peripheral Non-Small Cell Lung Cancer.
    J Comput Assist Tomogr. 2022 Apr 8. pii: 00004728-990000000-00015.
    PubMed     Abstract available


    March 2022
  25. MOON JW, Yi CA, Lee KS, Woo SY, et al
    Preoperative Helical Dynamic Enhanced Multidetector Row Computed Tomography: Can It Be a Prognostic Indicator in Early-Stage Non-small Cell Lung Cancer?
    J Comput Assist Tomogr. 2022;46:308-314.
    PubMed     Abstract available


  26. CHEN W, Xu M, Sun Y, Ji C, et al
    Integrative Predictive Models of Computed Tomography Texture Parameters and Hematological Parameters for Lymph Node Metastasis in Lung Adenocarcinomas.
    J Comput Assist Tomogr. 2022;46:315-324.
    PubMed     Abstract available


  27. HAN JY, Lee KN, Choi SJ, Baek JW, et al
    Is Free Breathing Possible During Computed Tomography-Guided Percutaneous Transthoracic Lung Biopsy? The Clinical Experience in 585 Cases.
    J Comput Assist Tomogr. 2022;46:294-299.
    PubMed     Abstract available


  28. ZHU LH, Wang FN, Wang YW, Cheng QH, et al
    Differentiation Between Solitary Pulmonary Inflammatory Lesions and Solitary Cancer Using Gemstone Spectral Imaging.
    J Comput Assist Tomogr. 2022;46:300-307.
    PubMed     Abstract available


    November 2021
  29. WANG B, Yu N, Han D, Ren Z, et al
    Computed Tomography Imaging Characteristics: Potential Indicators of Epidermal Growth Factor Receptor Mutation in Lung Adenocarcinoma.
    J Comput Assist Tomogr. 2021;45:964-969.
    PubMed     Abstract available


    September 2021
  30. LIU H, Wang J, Lang J, Zhang X, et al
    Pulmonary Epithelioid Hemangioendothelioma: Imaging and Clinical Features.
    J Comput Assist Tomogr. 2021;45:788-794.
    PubMed     Abstract available


  31. AZOUR L, Liu S, Washer SL, Moore WH, et al
    Percutaneous Transthoracic Lung Biopsy: Optimizing Yield and Mitigating Risk.
    J Comput Assist Tomogr. 2021;45:765-775.
    PubMed     Abstract available


    August 2021
  32. VOS D, Rao S, Pierce JD, Smith DA, et al
    The Past, Present, and Future (Liquid Biopsy) of Serum Tumor Markers in Lung Cancer: A Primer for the Radiologist.
    J Comput Assist Tomogr. 2021 Aug 2. pii: 00004728-900000000-98889.
    PubMed     Abstract available


    May 2021
  33. HU X, Gu Q, Zhang K, Deng D, et al
    Dual-Energy Computed Tomography for the Diagnosis of Mediastinal Lymph Node Metastasis in Lung Cancer Patients: A Preliminary Study.
    J Comput Assist Tomogr. 2021;45:490-494.
    PubMed     Abstract available


    March 2021
  34. CHANG AI, Kim TS, Han J, Kim TJ, et al
    NUT Midline Carcinoma of the Lung: Computed Tomography Findings in 10 Patients.
    J Comput Assist Tomogr. 2021;45:330-336.
    PubMed     Abstract available


  35. YEN A, Pfeffer Y, Blumenfeld A, Balcombe JN, et al
    Use of a Dual Artificial Intelligence Platform to Detect Unreported Lung Nodules.
    J Comput Assist Tomogr. 2021;45:318-322.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.